Olema Pharmaceuticals Stock Price Prediction
| OLMA Stock | USD 10.12 0.40 4.12% |
Oversold Vs Overbought
31
Oversold | Overbought |
EPS Estimate Next Quarter (0.63) | EPS Estimate Current Year (1.37) | EPS Estimate Next Year (2.59) | Wall Street Target Price 27.8571 | EPS Estimate Current Quarter (0.58) |
Using Olema Pharmaceuticals hype-based prediction, you can estimate the value of Olema Pharmaceuticals from the perspective of Olema Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Olema Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying Olema because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Olema Pharmaceuticals after-hype prediction price | USD 9.97 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Olema |
Olema Pharmaceuticals After-Hype Price Prediction Density Analysis
As far as predicting the price of Olema Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Olema Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Olema Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Olema Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Olema Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Olema Pharmaceuticals' historical news coverage. Olema Pharmaceuticals' after-hype downside and upside margins for the prediction period are 5.88 and 14.06, respectively. We have considered Olema Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Olema Pharmaceuticals is somewhat reliable at this time. Analysis and calculation of next after-hype price of Olema Pharmaceuticals is based on 3 months time horizon.
Olema Pharmaceuticals Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Olema Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Olema Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Olema Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.16 | 4.09 | 0.15 | 0.02 | 5 Events / Month | 13 Events / Month | In about 5 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
10.12 | 9.97 | 1.48 |
|
Olema Pharmaceuticals Hype Timeline
Olema Pharmaceuticals is now traded for 10.12. The entity has historical hype elasticity of -0.15, and average elasticity to hype of competition of 0.02. Olema is expected to decline in value after the next headline, with the price expected to drop to 9.97. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -1.48%, whereas the daily expected return is now at -0.16%. The volatility of related hype on Olema Pharmaceuticals is about 3876.78%, with the expected price after the next announcement by competition of 10.14. About 96.0% of the company shares are owned by institutional investors. The book value of Olema Pharmaceuticals was now reported as 3.47. The company recorded a loss per share of 2.28. Olema Pharmaceuticals had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 5 days. Check out Olema Pharmaceuticals Basic Forecasting Models to cross-verify your projections.Olema Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Olema Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Olema Pharmaceuticals' future price movements. Getting to know how Olema Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Olema Pharmaceuticals may potentially react to the hype associated with one of its peers.
Olema Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Olema price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Olema using various technical indicators. When you analyze Olema charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Olema Pharmaceuticals Predictive Indicators
The successful prediction of Olema Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Olema Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Olema Pharmaceuticals based on analysis of Olema Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Olema Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Olema Pharmaceuticals's related companies. | 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 31.85 | 12.62 | 12.33 | 11.71 | Net Debt To EBITDA | 4.09 | 0.2 | 0.63 | 0.6 |
Story Coverage note for Olema Pharmaceuticals
The number of cover stories for Olema Pharmaceuticals depends on current market conditions and Olema Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Olema Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Olema Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Olema Pharmaceuticals Short Properties
Olema Pharmaceuticals' future price predictability will typically decrease when Olema Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Olema Pharmaceuticals often depends not only on the future outlook of the potential Olema Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Olema Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 45.2 M | |
| Cash And Short Term Investments | 261.8 M |
Complementary Tools for Olema Stock analysis
When running Olema Pharmaceuticals' price analysis, check to measure Olema Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Olema Pharmaceuticals is operating at the current time. Most of Olema Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Olema Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Olema Pharmaceuticals' price. Additionally, you may evaluate how the addition of Olema Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |